ArticleThe British journal of ophthalmology2015

UK AMD EMR USERS GROUP REPORT V: benefits of initiating ranibizumab therapy for neovascular AMD in eyes with vision better than 6/12.

Aaron Y Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.